Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4321

1.

Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.

Shi J, Li S, Gao A, Zhu K, Zhang H.

Phytomedicine. 2018 Jul 15;46:21-31. doi: 10.1016/j.phymed.2018.06.003. Epub 2018 Jun 10.

PMID:
30097119
2.

A case report of purulent pericarditis caused by Candida albicans: Delayed complication forty-years after esophageal surgery.

Sung J, Perez IE, Feinstein A, Stein DK.

Medicine (Baltimore). 2018 Jul;97(28):e11286. doi: 10.1097/MD.0000000000011286.

3.

Clinical and laboratorial features of oral candidiasis in HIV-positive patients.

Spalanzani RN, Mattos K, Marques LI, Barros PFD, Pereira PIP, Paniago AMM, Mendes RP, Chang MR.

Rev Soc Bras Med Trop. 2018 May-Jun;51(3):352-356. doi: 10.1590/0037-8682-0241-2017.

4.

Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death.

Pasternak B, Wintzell V, Furu K, Engeland A, Neovius M, Stephansson O.

JAMA. 2018 Jun 12;319(22):2333-2335. doi: 10.1001/jama.2018.6237. No abstract available.

PMID:
29896619
5.

Intracranial Cryptococcoma-Clinicopathologic Correlation and Surgical Outcome: A Single-Institution Experience.

Uppar A, Raj ARP, Konar S, Kandregula S, Shukla D, Somanna S, Devi BI, C Y, Chandrashekar N.

World Neurosurg. 2018 Jul;115:e349-e359. doi: 10.1016/j.wneu.2018.04.056. Epub 2018 Apr 17.

PMID:
29678697
6.

Effect of fluconazole on the pharmacokinetics of everolimus and tacrolimus in a heart transplant recipient: Case report.

Nakagita K, Wada K, Terada Y, Matsuda S, Terakawa N, Oita A, Takada M.

Int J Clin Pharmacol Ther. 2018 Jun;56(6):270-276. doi: 10.5414/CP203209.

PMID:
29648533
7.

Pediatric Old World cutaneous leishmaniasis treated with oral fluconazole: A case series.

Michelerio A, Barruscotti S, Bossi G, Brazzelli V.

Pediatr Dermatol. 2018 May;35(3):384-387. doi: 10.1111/pde.13493. Epub 2018 Mar 26.

PMID:
29582455
8.

Biogenic nanosilver synthesized in Metarhizium robertsii waste mycelium extract - As a modulator of Candida albicans morphogenesis, membrane lipidome and biofilm.

Różalska B, Sadowska B, Budzyńska A, Bernat P, Różalska S.

PLoS One. 2018 Mar 19;13(3):e0194254. doi: 10.1371/journal.pone.0194254. eCollection 2018.

9.

Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans.

Ng SMS, Yap JM, Lau QY, Ng FM, Ong EHQ, Barkham T, Teo JWP, Alfatah M, Kong KW, Hoon S, Arumugam P, Hill J, Brian Chia CS.

Eur J Med Chem. 2018 Apr 25;150:479-490. doi: 10.1016/j.ejmech.2018.03.027. Epub 2018 Mar 9.

PMID:
29549835
10.

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team.

N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922.

11.

Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.

Sun L, Liao K, Hang C.

Phytomedicine. 2018 Feb 1;40:55-58. doi: 10.1016/j.phymed.2017.12.033. Epub 2018 Jan 2.

PMID:
29496175
12.

[Otomycosis: the modern view of etiology and management].

Kryukov AI, Kunel'skaya NL, Kunel'skaya VY, Ivoilov AY, Turovskiy AB, Shadrin GB, Machulin AI.

Vestn Otorinolaringol. 2018;83(1):48-51. doi: 10.17116/otorino201883148-51. Russian.

PMID:
29488497
13.

Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.

Francesconi VA, Francesconi F, Ramasawmy R, Romero GAS, Alecrim MDGC.

PLoS Negl Trop Dis. 2018 Feb 26;12(2):e0006225. doi: 10.1371/journal.pntd.0006225. eCollection 2018 Feb.

14.

Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans.

Huang MC, Shen M, Huang YJ, Lin HC, Chen CT.

Int J Mol Sci. 2018 Feb 1;19(2). pii: E434. doi: 10.3390/ijms19020434.

15.

Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.

Carreira A, Ferreira JB, Pereira I, Ferreira J, Filipe P, Ferreira RB, Monteiro S.

J Med Microbiol. 2018 Feb;67(2):198-207. doi: 10.1099/jmm.0.000675.

PMID:
29388537
16.

An in Vitro Study on the Effect of Combined Treatment with Photodynamic and Chemical Therapies on Candida albicans.

Hsieh YH, Zhang JH, Chuang WC, Yu KH, Huang XB, Lee YC, Lee CI.

Int J Mol Sci. 2018 Jan 24;19(2). pii: E337. doi: 10.3390/ijms19020337.

17.

Nanolipid Gel of an Antimycotic Drug for Treating Vulvovaginal Candidiasis-Development and Evaluation.

Takalkar D, Desai N.

AAPS PharmSciTech. 2018 Apr;19(3):1297-1307. doi: 10.1208/s12249-017-0918-7. Epub 2018 Jan 16.

PMID:
29340981
18.

Variability in the clinical distributions of Candida species and the emergence of azole-resistant non-Candida albicans species in public hospitals in the Midwest region of Brazil.

Mattos K, Rodrigues LC, Oliveira KMP, Diniz PF, Marques LI, Araujo AA, Chang MR.

Rev Soc Bras Med Trop. 2017 Nov-Dec;50(6):843-847. doi: 10.1590/0037-8682-0163-2017.

19.

Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.

Aslani N, Janbabaei G, Abastabar M, Meis JF, Babaeian M, Khodavaisy S, Boekhout T, Badali H.

BMC Infect Dis. 2018 Jan 8;18(1):24. doi: 10.1186/s12879-017-2916-5.

20.

Novel fluconazole derivatives with promising antifungal activity.

Thamban Chandrika N, Shrestha SK, Ngo HX, Howard KC, Garneau-Tsodikova S.

Bioorg Med Chem. 2018 Feb 1;26(3):573-580. doi: 10.1016/j.bmc.2017.12.018. Epub 2017 Dec 17.

PMID:
29279242

Supplemental Content

Loading ...
Support Center